Daiichi Sankyo Says No Plans To Shut Ranbaxy Bulk Drug Plant In India
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo says it has no plans to close the Ranbaxy Laboratories plant in India for manufacturing bulk drugs